期刊文献+

SF-36量表在糖尿病和糖耐量减低患者生命质量研究中的信度、敏感性和可行性评价 被引量:43

Evaluation on reliability,sensitivity and feasibility of SF-36 instrument with the quality of life in DM and IGT
下载PDF
导出
摘要 目的 :评价SF -36量表在我国糖尿病(DM)和糖耐量低减(IGT)患者生命质量研究中的信度、敏感性和可行性。方法 :通过对DM、IGT患者和糖耐量正常者(NGT)使用SF -36量表的生命质量(QualityofLifeQL)自评数据进行评价。结果 :DM和IGT的劈半信度分别为0.93和0.84 ;总量表的Cronbach'sα系数、θ系数和Ω系数均>0.9 ,分量表的8个维度除了精力分项(最低为0.57)外 ,其余各维度的三系数(至少有一项)均达到一般认可的标准以上 ;QL各维度评分的大多数(18/24)和综合评分为DM<IGT<NGT,且某些维度和综合评分的差异显著(P<0.05) ;研究对象对量表的接受率和完成率均为100 % ,完成时间平均5min。结论 :SF -36量表信度良好 ,敏感性可 ,可行性好 ,适合应用于我国DM和IGT患者QL的研究。 Objective:To evaluate the reliability,sensitivity and feasibility of SF-36 instrument with the quality of life in DM and IGT.Methods:With the self assessed data of quality of life in subjects with DM,IGT and NGT from a prevalence study,the reliability,sensitivity and feasibility of SF-36 instrument have been evaluated.Results:In patients with DM and IGT,the spilt half reliability was 0.93 and 0.84 respectively,cronbach's αcoefficient,theta(θ) coefficient and omegea(Ω) coefficient of SF-36 instrument was over 0.9,the SF-36 instrument including eight multitem dimemsions,except in vitality(the lowest was 0.57),the three coefficients(at least one of them)attained or exceed the accepatable criterion(≥0.8 is excellent,≥0.7 is good).Most of mean(18/24) score of quality of life in dimensions and instrument was the lowest in DM and the highest in NGT,mean score of four dimensions and the instrument in DM was apparently differenct with in NGT(P< 0.05),while compared in DM and in IGT,mean score of two dimensions was apparently different,the acceptable and completed rate was 100 percent,the average completed time was 5 minutes.Conclusion :The reliability,sensitivity of SF-36 instrument are excellent,it's feasibility is satisfying.the SF-36 is a suitable instrument in DM and IGT in China.
出处 《现代康复》 CSCD 2000年第4期544-545,共2页 Modern Rehabilitation
关键词 SF-36量表 信度 生命质量 糖尿病 SF-36 reliability quality of life diabetes mellitus
  • 相关文献

参考文献8

  • 1Stewart AL,Hays RD,Ware JE.The MOS short form general health sur-vey: reliablity and validity in a patient population[J].Med Care,1988, 26:724~ 735
  • 2Jacobson AM,Samson JA,Grout MD,et al.The evaluation of two mea-sures of quality of life in patients with type 1 and type 2 diabetes[J].Dia-betes Care,1994,17:267~ 274
  • 3Johnson JR,Temple R.Food and drug administration requirements for approval of new anticancer drugs[J].Cancer Treat Rep,1985,69:1 155~1 158
  • 4World Health Organization.Diabetes mellius:report of a study group[C]. Geneva:WHO Tech Rep Ser.1985.25~ 26
  • 5Johnson JA,Nowatzki TZ,Pharmd,et al.Health related quality of life of diabetic Pima indians[J].Med Care,1996,34:97~ 102
  • 6Waltz CF.Measurement in nursing research[M].Philadelphia:FA.Davis Company.1991.48~ 50
  • 7Nunnally JC,Bernstein IH.Psychometric Theory[M].New York:Mc Graw Hill,INC.1994.22~ 124
  • 8Streiner DL,Norman GR.Health measurement scales:a practical guide to their develepment and use[M].Oxford,New York.Tokyo.Oxford university press.1994.136~ 138

同被引文献347

引证文献43

二级引证文献540

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部